Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Why choose RGCC

RGCC was launched in 2004 by genetics pioneer
Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively.

His belief that personalized medicine using the information in a patient’s genes is the way forward lies at the very heart of everything we do.

Revolutionary liquid biopsies

Our liquid biopsies represent a revolutionary approach to cancer testing and research, offering distinct advantages over traditional tissue biopsies. Minimally invasive and more convenient, liquid biopsies involve a simple blood draw, making them patient-friendly. Moreover, they are cost-effective, enhancing accessibility for patients and healthcare providers alike.

Additionally, unlike traditional biopsies that offer insights from one specific location in the body, liquid biopsies capture information from distant (metastatic) sites as well. This means that liquid biopsies paint a complete picture of cancer throughout the patient's body, offering a comprehensive perspective that can be invaluable for precise diagnosis and treatment planning.

Comprehensive insights at a fraction of the cost

Unlike other labs, our Circulating Tumor Cell (CTC) tests are uniquely designed on negative selection technology, ensuring all cancer populations are accounted for, and only non-cancer cells are discarded before analysis. This comprehensive approach provides a more complete (and true) count of your CTCs, offering a more accurate picture of your cancer status.

Testing both chemotherapeutic & natural substances

At RGCC, we understand that treatment options go beyond traditional chemotherapy. Our tests evaluate the effectiveness of over 50 chemotherapeutic agents alongside natural substances. This holistic approach not only expands treatment options for you to choose from, it also helps identify treatments that work best for you!

Real-time insights for better outcomes

Liquid biopsies provide a comprehensive, real-time view of a patient’s cancer status. Frequent testing allows continuous monitoring, facilitating prompt adjustments to treatment plans.

These tests also reveal the genetic composition of the cancer, enabling the identification of highly effective treatments tailored to individual biology. This personalized approach helps you choose treatments that will likely have the greatest chance of showing a positive result for your body and cancer.

Advancing personalized medicine

Our commitment extends to advancing personalized medicine through relentless research and innovation. Our experts continually strive to develop new diagnostic and therapeutic options for cancer.

Our liquid biopsy tests analyze circulating tumor cells (CTCs) and associated biomarkers in the bloodstream. This provides comprehensive insights into a patient’s cancer, guiding treatment decisions and monitoring disease progression.

Leading the way in personalized medicine

Our team is at the forefront of the quest for more personalized and precise cancer treatments. We are globally recognized as the leading center in the field of personalized medicine, developing cutting-edge technologies that can help identify the most effective treatments for each individual patient.

Innovative solutions for your health

At RGCC, we are committed to providing innovative solutions for cancer and chronic diseases. Our global mission is to help patients across the world have access to the latest diagnostic and therapeutic options for their conditions.

Where science meets precision

Our state-of-the-art laboratory facilities in Europe are equipped with the latest technology and staffed by world-class experts.

Our scientists are dedicated to pioneering research that propels the field of personalized medicine forward. We use innovative techniques to provide timely and precise information so patients and their practitioners can take therapeutic action based on results that provide granular levels of detail about their condition.

A vision for better health

At RGCC, we envision a future where cancer treatment is truly personalized and targeted to meet each patient’s unique needs. Through our research and innovation, we work tirelessly to turn this vision into reality, offering renewed hope to patients and their families worldwide.

Experience excellence in care

Excellence is at the core of everything we do at RGCC, from the quality of our tests and protocols to the support we provide to patients and practitioners. Whether you’re a patient seeking hope or a healthcare professional dedicated to improving patient outcomes, we welcome the opportunity to collaborate and provide personalized solutions that make a real difference.

Get in touch today!
Follow Us
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map